Multivalent entrain-and-amplify immunotherapeutics for carcinoma

Details for Australian Patent Application No. 2006259221 (hide)

Owner MannKind Corporation

Inventors Diamond, David C.; Smith, Kent; Liu, Liping; Gong, Jian; Chiang, Chi-Sheng; Qiu, Zhiyong; Liu, Xiping; Bot, Adrian

Agent Davies Collison Cave

Pub. Number AU-B-2006259221

PCT Pub. Number WO2006/138568

Priority 60/691,581 17.06.05 US

Filing date 16 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 4 October 2012

International Classifications

A61K 39/00 Medicinal preparations containing antigens or antibodies

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138568 Priority application(s): WO2006/138568

21 February 2008 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Sheng-Chiang, Chih to Chiang, ChiSheng

4 October 2012 Application Accepted

  Published as AU-B-2006259221

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259223-Serving base station selection in a wireless communication system

2006259220-Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma